Stoichiometric expression of MMP-2/TIMP-2 in benign and malignant tumours of the salivary gland
- 100 Downloads
The aim of this study was to determine the expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitors of matrix metalloproteinase 2 (TIMP-2) and the MMP-2/TIMP-2 expression ratio in salivary gland tumours (SGTs). Forty-three FFPE SGTs were prepared for antibody processing to MMP-2 and TIMP-2. Two investigators utilizing Sinicrope’s method scored the uptake of immuno-stains. Cytoplasmic staining was considered as positive. Data was analysed using SPSS version 20. The significance level was set at p < 0.05. In benign SGTs, the mean score for MMP-2 was not significantly lower than that of TIMP-2 (p = 0.37). However, the mean scores for MMP-2 stain intensity and proportion were significantly higher in malignant than benign SGTs (p = 0.01 and p = 0.02 respectively). There was no significant difference in the mean MMP-2/TIMP-2 expression ratio of the malignant SGTs according to histological grade and histogenesis (p = 0.4 and p = 0.19 respectively). The MMP-2/TIMP-2 expression ratio has a higher prognostic value than the separate expressions of MMP-2 and TIMP-2.
KeywordsMatrix metalloproteinase-2 Tissue inhibitor of matrix metalloproteinase-2 Salivary gland tumours
All the authors declare that there are no disclosures to make and that this was a self-funded study.
Conflicts of interest
- 4.Stettler-Stevenson WG, Krutzsch HC, Liotta LA. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family. Matrix Suppl. 1992;1:299–306.Google Scholar
- 12.AL-Rawi NH, Al-Samarai M, Al-Kawas S, Majeed AH. Expression of matrix metalloproteinase MMP-2 and its tissue inhibitor TIMP-2 in intraoral pleomorphic adenoma and adenoid cystic carcinoma. J Int Dent Med Res. 2011;4:1–6.Google Scholar
- 17.Taher MG, Abdullah BH, Al-Kari LE. Expression of MMP-2 as biological markers of invasion potential in mucoepidermoid carcinoma of the oral and maxillofacial region (immunohistochemical study). Diyala J Med. 2012;3:67–72.Google Scholar
- 23.Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomedical Sci. 2010;17(10):1–13.Google Scholar